Interim phase 2 analysis shows zamto-cel activity in DLBCL
The chimeric antigen receptor T-cell therapy zamtocabtagene autoleucel (zamto-cel) showed encouraging activity and a favorable safety profile in patients with relapsed or refractory
2026 Tandem Meetings
Cellular Therapy
Lymphoma
Aggressive B-Cell Lymphomas
Meetings / Conferences
News
ASH 2025
Leukemia
Dr. Lane discusses results of triplet combo in BPCDN
Andrew Lane, MD, PhD, of Dana Farber Cancer Institute, reports the results from a phase 2 trial in tagraxofusp, azacitidine, and venetoclax (TAG-AZA-VEN) triplet
SOHO UK
Leukemia
Acute Myeloid Leukemia
News
New therapies push UK registries into central role
The future of registries in the UK came into focus during an afternoon session at SOHO UK with Priyanka Mehta, MBBS, MD, FRCP,
SOHO UK
Leukemia
Acute Lymphoblastic Leukemia
Lymphoma
Aggressive B-Cell Lymphomas
News
Q&A: Dr. Gohil on the multidisciplinary approach to HLH
During the HLH portion of the How I Treat or Manage session at 9.00-9.20 on 4 March, Dr. Gohil will discuss how the
Cellular Therapy
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Multiple Myeloma
Myelodysplastic Syndromes
News
Why clinicians should lead hospitals, according to Prof. Amanda Goodall
Prof. Amanda Goodall, director of the Executive Master's in Medical Leadership (EMML), a specialized MSc degree from Bayes Business School offering advanced leadership
SOHO UK
Cellular Therapy
Lymphoma
Aggressive B-Cell Lymphomas
Indolent B-Cell Lymphomas
News
Prof. Peter Johnson, CBE, on accelerating cancer trials in the UK
In five years, we hope to have a national system for prescreening to determine eligibility for experimental cancer medicine, allowing the UK to
SOHO UK
Leukemia
Acute Lymphoblastic Leukemia
Lymphoma
Aggressive B-Cell Lymphomas
DIDACT’s mission to train and mentor the next generation of UK blood cancer triallists
The DIDACT Foundation was established with the mission to expand structured training and mentoring opportunities in clinical trial delivery for trainee UK haematologists.
SOHO UK
Leukemia
Acute Lymphoblastic Leukemia
News
Society Updates
SOHO UK mirrors traditional SOHO meeting with UK twist
SOHO UK is intended to set a precedent as the start of a continuing platform that will return at regular intervals and provide
SOHO UK
Lymphoma
Aggressive B-Cell Lymphomas
T-Cell Lymphoma
Meetings / Conferences
Prof. Cwynarski previews CNS, peripheral T-cell lymphoma sessions ahead of SOHO UK
Prof. Kate Cwynarski, MD, PhD, joined SOHO Insider podcast host Megan Melody, MD, for a discussion previewing lymphoma sessions she will lead at
Cellular Therapy
Lymphoma
Indolent B-Cell Lymphomas
News
Liso-cel shows good 3-year response, safety results in patients with R/R follicular lymphoma
Patients in the TRANSCEND FL study received liso-cel after lymphodepleting chemotherapy (LDC). Bridging therapy was allowed with reconfirmation of PET-positive disease before LDC.